Your browser doesn't support javascript.
loading
New variants and in silico analyses in GRK1 associated Oguchi disease.
Poulter, James A; Gravett, Molly S C; Taylor, Rachel L; Fujinami, Kaoru; De Zaeytijd, Julie; Bellingham, James; Rehman, Atta Ur; Hayashi, Takaaki; Kondo, Mineo; Rehman, Abdur; Ansar, Muhammad; Donnelly, Dan; Toomes, Carmel; Ali, Manir; De Baere, Elfride; Leroy, Bart P; Davies, Nigel P; Henderson, Robert H; Webster, Andrew R; Rivolta, Carlo; Zeitz, Christina; Mahroo, Omar A; Arno, Gavin; Black, Graeme C M; McKibbin, Martin; Harris, Sarah A; Khan, Kamron N; Inglehearn, Chris F.
Affiliation
  • Poulter JA; Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Gravett MSC; School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
  • Taylor RL; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK.
  • Fujinami K; National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Centre, Tokyo, Japan.
  • De Zaeytijd J; Moorfields Eye Hospital, London, UK.
  • Bellingham J; UCL Institute of Ophthalmology, London, UK.
  • Rehman AU; Keio University School of Medicine, Tokyo, Japan.
  • Hayashi T; Ghent University, Ghent, Belgium.
  • Kondo M; UCL Institute of Ophthalmology, London, UK.
  • Rehman A; Division of Genetic Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland.
  • Ansar M; The Jikei University School of Medicine, Tokyo, Japan.
  • Donnelly D; Mie University Graduate School of Medicine, Mie, Japan.
  • Toomes C; Department of Genetics, Faculty of Science, Hazara University Mansehra, Dhodial, Pakistan.
  • Ali M; Clinical Research Center, Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
  • De Baere E; Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Leroy BP; Division of Molecular Medicine, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Henderson RH; Ghent University, Ghent, Belgium.
  • Webster AR; Ghent University, Ghent, Belgium.
  • Rivolta C; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Zeitz C; St Thomas's Hospital, London, UK.
  • Mahroo OA; Department of Ophthalmology, Great Ormond Street Hospital, London, UK.
  • Arno G; Moorfields Eye Hospital, London, UK.
  • Black GCM; UCL Institute of Ophthalmology, London, UK.
  • McKibbin M; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
  • Harris SA; Clinical Research Center, Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
  • Khan KN; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.
  • Inglehearn CF; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Hum Mutat ; 42(2): 164-176, 2021 02.
Article in En | MEDLINE | ID: mdl-33252155
ABSTRACT
Biallelic mutations in G-Protein coupled receptor kinase 1 (GRK1) cause Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB). The purpose of this study was to identify disease causing GRK1 variants and use in-depth bioinformatic analyses to evaluate how their impact on protein structure could lead to pathogenicity. Patients' genomic DNA was sequenced by whole genome, whole exome or focused exome sequencing. Disease associated variants, published and novel, were compared to nondisease associated missense variants. The impact of GRK1 missense variants at the protein level were then predicted using a series of computational tools. We identified twelve previously unpublished cases with biallelic disease associated GRK1 variants, including eight novel variants, and reviewed all GRK1 disease associated variants. Further structure-based scoring revealed a hotspot for missense variants in the kinase domain. In addition, to aid future clinical interpretation, we identified the bioinformatics tools best able to differentiate disease associated from nondisease associated variants. We identified GRK1 variants in Oguchi disease patients and investigated how disease-causing variants may impede protein function in-silico.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eye Diseases, Hereditary / Night Blindness / G-Protein-Coupled Receptor Kinase 1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hum Mutat Journal subject: GENETICA MEDICA Year: 2021 Document type: Article Affiliation country: United kingdom Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eye Diseases, Hereditary / Night Blindness / G-Protein-Coupled Receptor Kinase 1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hum Mutat Journal subject: GENETICA MEDICA Year: 2021 Document type: Article Affiliation country: United kingdom Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA